We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > 7 Hills Pharma

News List

7 Hills Pharma Receives NCI Grant for Immunostimulant Trials americanpharmaceuticalreview
September 23, 2020
7 Hills Pharma has been awarded a two-year, $2 million Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) of the U.S. National Institutes of Health.
7 Hills Pharma Announces Positive Data with Oral Immunostimulant to Improve Effectiveness of COVID-19 Vaccines americanpharmaceuticalreview
July 16, 2020
7 Hills Pharma announced preclinical studies reveal 7HP349, an oral integrin activator that promotes cell adhesion, significantly increases IgG binding antibodies with a vaccine targeting SARS-CoV-2 (COV2), the virus that causes COVID-19.
7 Hills Announces Positive Data On 7HP349 contractpharma
July 08, 2020
Studies show the small molecule adjuvant increases IgG binding antibody responses.
7 Hills Pharma Announces FDA Clearance of IND Application for Immune Stimulant americanpharmaceuticalreview
April 15, 2020
7 Hills Pharma announced the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for 7HP349.